Korea's largest startup festival, COMEUP 2025, opens on December 10 (KST), bringing together innovative startups, global and domestic investors, and major corporations. From December 10–12 at COEX ...
A Global Startup Festival Co-hosted by the Ministry of SMEs and Startups (MSS) and Korea Startup Forum (KSF) From December 10–12 at COEX Seoul, the three-day festival will bring together innovative ...
Seattle police search for hit-and-run suspect after cannabis store worker injured in SODO The Seattle Police Department (SPD) is searching for a hit-and-run suspect who drove over a man in SODO on ...
– RCT2100 co-administered with ivacaftor will assess the safety and tolerability of inhaled CFTR mRNA therapy over 6 weeks in participants with CF – – U.S. sites now enrolling, with U.K. and EU sites ...
MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, ...
ReCode Therapeutics Initiates Enrollment of Phase 2 Clinical Trial of RCT2100 in Combination with Ivacaftor for the Treatment of Cystic Fibrosis – RCT2100 co-administered with ivacaftor will assess ...
As the partisan divide over what it means to improve government has increasingly deepened, one new nonprofit — boasting buy-in from both sides of the aisle — aims to raise and funnel $120 million into ...
A new philanthropic initiative aims to reimagine the government’s workforce, technology systems and tools, and it was announced recently via a blog by Jennifer Pahlka, who is the chair of the board of ...
– Cystic Fibrosis Foundation provides $3 million in new funding to accelerate development of inhaled mRNA therapy for cystic fibrosis – – Research collaboration with Praxis Precision Medicines to ...
– Cystic Fibrosis Foundation provides $3 million in new funding to accelerate development of inhaled mRNA therapy for cystic fibrosis – – Research collaboration with Praxis Precision Medicines (PRAX) ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果